DERM Dermira, Inc.

NASDAQ
$4.33

Dermira, Inc. (DERM) Earnings News

Earnings press releases, previews and reviews for Dermira, Inc. (DERM), newest first. Our most recent is review: Journey Medical (DERM) Misses as Emrosi Momentum Cools and Promised Guidance Slips, Leaving a 2027 Formulary Win to Carry the Story.